Revolutionizing Tube Feeding: Innovative Solutions Inspired by Real Patients to Benefit Thousands
Cardinal Health at-Home Solutions plays a crucial role in equipping patients and caregivers with essential tools for in-home care. This article is part of a series shedding light on the innovations, products, and services the business delivers directly to the…
Zero Suicide Institute Unveils Toolkit for Pediatric Health Systems to Prevent Suicide
The escalating concern of pediatric suicide has become a pressing issue, with more than 25% of youth deaths in the U.S. attributed to suicide, as noted by the American Academy of Pediatricians. According to the Centers for Disease Control (CDC),…
Cencora to Host First-Ever ThinkLive Cell and Gene Therapy Summit
A global healthcare company is set to host its inaugural ThinkLive Cell and Gene Therapy (CGT) Summit, bringing together leaders from the healthcare and biopharmaceutical industries. This two-day virtual event, commencing on May 14, aims to delve into the latest…
Meridian and Centene Foundation Award $1.1 Million Grant to Neighborhood Service Organization in Michigan
Today, Meridian, a prominent managed care organization in Michigan and a wholly-owned subsidiary of Centene Corporation, along with the Centene Foundation, the philanthropic arm of Centene Corporation, announced a generous $1.1 million grant to the Neighborhood Service Organization (NSO), an…
Siemens Healthiness Unveils £250m Oxford Facility, UK’s First Major MRI Cooling Tech Production Site
Siemens Healthineers announced a new £250 million ($314 million) facility in North Oxfordshire, set to revolutionize MRI technology globally. This innovative site will design and manufacture superconducting magnets for MRI patient scans, employing novel DryCool technology that reduces helium usage…
Siemens Healthiness Nearing Fiscal Year 2024 Goals Following Strong Second Quarter Performance
Quarter 2 of Fiscal Year 2024: Outlook for Fiscal Year 2024: Bernd Montag, CEO of Siemens Healthiness AG, states: “The Healthineers team has continued its successful growth trajectory, even relative to an excellent prior-year quarter. After an overall strong first…
Findings from CVS Health® Survey Reveal Increasing Mental Health Worries
A recent survey conducted by CVS Health® in collaboration with Morning Consult has revealed a growing concern among adults regarding mental health issues, with rates steadily increasing across the nation. The survey indicates that two-thirds (65%) of adults have expressed…
Community Safety Enhanced Through Prevention Initiatives
Substance misuse continues to pose a significant challenge in the United States. Prevention, defined as any action aimed at averting substance misuse and lessening its adverse health and societal impacts, plays a crucial role in promoting mental well-being, preventing substance…
The Arc & United Health Foundation: $2.5M Partnership Targets Mental Health Crisis for Disabled
United Health Foundation, the philanthropic arm of UnitedHealth Group , has bestowed a generous three-year, $2.5 million grant upon The Arc of the United States. This grant aims to enhance mental health care for individuals with intellectual and developmental disabilities…
KKR Acquiring Healthium from Apax Funds
Today, KKR, a prominent global investment firm, revealed the finalization of agreements whereby KKR-managed funds will purchase Healthium Medtech Ltd. (“Healthium”), a top Indian medical devices company, from an affiliate of Funds advised by Apax Partners LLP (“Apax”), a renowned…
MindMed Unveils MM120 Phase 2b Study for GAD at APA Annual Meeting
MindMed (NASDAQ: MNMD), a clinical-stage biopharmaceutical company focused on developing innovative treatments for brain health disorders, unveiled data from its Phase 2b study of MM120 (lysergide d-tartrate) for treating Generalized Anxiety Disorder (GAD) in adults. The study, known as MMED008,…
UroGen Reveals Strong UGN-102 Response in Low-Grade Bladder Cancer
UroGen Pharma Ltd. (Nasdaq: URGN), a biotech firm focused on pioneering treatments for urothelial and specialty cancers, has unveiled findings from a fresh examination of the ATLAS trial. This analysis employs Kaplan Meier techniques to gauge the likelihood of sustained…